Type 2 diabetes: ceramides as a therapeutic target?

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.6, 2013-12, pp. : 607-609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes

By Pratley Richard E. Salsali Afshin

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 919-931

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 427-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Screening for type 2 diabetes

By Macrae Malcolm J

British Journal of General Practice, Vol. 54, Iss. 507, 2004-10 ,pp. : 785-785

Royal College of General Practitioners

Access to resources Recommend Favorite

Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies

By Meece Jerry

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 933-944

Informa Healthcare

Access to resources Recommend Favorite

Target intervention against multiple‐risk markers to reduce cardiovascular disease in patients with type 2 diabetes

By Gæde Peter Pedersen Oluf

Annals of Medicine, Vol. 36, Iss. 5, 2004-09 ,pp. : 355-366

Informa Healthcare

Access to resources Recommend Favorite